Back to Search
Start Over
MO01.01 Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy.
- Source :
- Journal of Thoracic Oncology; 2021 Supplement, Vol. 16 Issue 1, pS15-S15, 1p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 16
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 148633541
- Full Text :
- https://doi.org/10.1016/j.jtho.2020.10.049